Stockreport

Arcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress

Arcturus Therapeutics Holdings Inc.  (ARCT) 
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arcturusrx.com/investor-relations
PDF $200 million upfront payment received in December 2022 from CSL collaborationAchieved $90 million in development milestones in March 2023 under CSL collaborationARCT-154 [Read more]